TITLE

2D-QSAR model development and analysis on variant groups of anti -tuberculosis drugs

AUTHOR(S)
Dwivedi, Neeraja; Mishra, Bhartendu Nath; Katoch, Vishwa Mohan
PUB. DATE
August 2011
SOURCE
Bioinformation;2011, Vol. 7 Issue 2, p82
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A quantitative structure activity relationship study was performed on different groups of anti-tuberculosis drug compound for establishing quantitative relationship between biological activity and their physicochemical /structural properties. In recent years, a large number of herbal drugs are promoted in treatment of tuberculosis especially due to the emergence of MDR (multi drug resistance) and XDR (extensive drug resistance) tuberculosis. Multidrug-resistant TB (MDR-TB) is resistant to front-line drugs (isoniazid and rifampicin, the most powerful anti-TB drugs) and extensively drug-resistant TB (XDR-TB) is resistant to front-line and second-line drugs. The possibility of drug resistance TB increases when patient does not take prescribed drugs for defined time period. Natural products (secondary metabolites) isolated from the variety of sources including terrestrial and marine plants and animals, and microorganisms, have been recognized as having antituberculosis action and have recently been tested preclinically for their growth inhibitory activity towards Mycobacterium tuberculosis or related organisms. A quantitative structure activity relationship (QSAR) studies were performed to explore the antituberculosis compound from the derivatives of natural products . Theoretical results are in accord with the in vitro experimental data with reported growth inhibitory activity towards Mycobacterium tuberculosis or related organisms. Antitubercular activity was predicted through QSAR model, developed by forward feed multiple linear regression method with leave-one-out approach. Relationship correlating measure of QSAR model was 74% (R2 = 0.74) and predictive accuracy was 72% (RCV2 = 0.72). QSAR studies indicate that dipole energy and heat of formation correlate well with anti-tubercular activity. These results could offer useful references for understanding mechanisms and directing the molecular design of new lead compounds with improved anti-tubercular activity. The generated QSAR model revealed the importance of structural, thermodynamic and electro topological parameters. The quantitative structure activity relationship provides important structural insight in designing of potent antitubercular agent.
ACCESSION #
71827410

 

Related Articles

  • Three-Dimensional Quantitative Structure-Activity Relationships for a Large Series of Potent Antitubercular Agents. Andrade, Carolina Horta; Salum, Lívia de Barros; Mesquita Pasqualoto, Kerly Fernanda; Ferreira, Elizabeth Igne; Andricopulo, Adriano Defini // Letters in Drug Design & Discovery;Sep2008, Vol. 5 Issue 6, p377 

    Comparative molecular field analysis (CoMFA) studies were conducted on a series of 100 isoniazid derivatives as anti-tuberculosis agents using two receptor-independent structural data set alignment strategies: (1) rigid-body fit, and (2) pharmacophore-based. Significant cross-validated...

  • Synthesis, antituberculosis activity and QSAR study of some novel 2-(nitroaryl)-5-(nitrobenzylsulfinyl and sulfonyl)-1,3,4-thiadiazole derivatives. A., Foroumadi; A., Sakhteman; Z., Sharifzadeh; N., Mohammadhosseini; B., Hemmateenejad; M. H., Moshafi; M., Vosooghi; M., Amini; A., Shafiee // DARU;2007, Vol. 15 Issue 4, p218 

    Background and the purpose of the study: In continuation of our research program for new antitubercular agents, some hybrid compounds containing a 5-nitrohetrocyle and 1,3,4-thiadiazole ring have been synthesized and their antituberculosis activity have been evaluated. QSAR studies were...

  • Prevalence of multidrug-resistant tuberculosis among Category II pulmonary tuberculosis patients. Sharma, Surendra K.; Kumar, Sanjeev; Saha, P. K.; George, Ninoo; Arora, S. K.; Gupta, Deepak; Singh, Urvashi; Hanif, M.; Vashisht, R. P. // Indian Journal of Medical Research;Mar2011, Vol. 133 Issue 3, p312 

    Background & objectives: Multidrug-resistant tuberculosis (MDR-TB) has emerged as a significant global health concern. The most important risk factor for the development of MDR-TB is previous antituberculosis therapy. Category II pulmonary TB includes those patients who had failed previous TB...

  • Multiple Side Effects Of Second Line Antitubercular Therapy In A Single Patient. Verma, S.K.; Mahajan, Vineet // Internet Journal of Pulmonary Medicine;2008, Vol. 9 Issue 2, p11 

    Treatment of Multi-Drug Resistant Tuberculosis (MDR-TB) with second line anti tubercular drugs is associated with lot of side effects which can be dangerous. Here we are reporting a case of MDR-TB having multiple side effects from second line chemotherapy in the same patient which is a rare...

  • Turning the tables on TB. PAYNE, RICHARD // Chemistry in Australia;Oct2013, p16 

    The article offers information on the treatment of tuberculosis (TB) using drug comprising a combination therapy of four drugs (rifampicin, isoniazid, ethambutol and pyrazinamide) for six months, alongside observation of the treatment course by a medical professional. However, poor adherence to...

  • Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds. Makowska-Grzyska, Magdalena; Kim, Youngchang; Gorla, Suresh Kumar; Wei, Yang; Mandapati, Kavitha; Zhang, Minjia; Maltseva, Natalia; Modi, Gyan; Boshoff, Helena I.; Gu, Minyi; Aldrich, Courtney; Cuny, Gregory D.; Hedstrom, Lizbeth; Joachimiak, Andrzej // PLoS ONE;10/6/2015, Vol. 10 Issue 10, p1 

    Tuberculosis (TB) remains a worldwide problem and the need for new drugs is increasingly more urgent with the emergence of multidrug- and extensively-drug resistant TB. Inosine 5’-monophosphate dehydrogenase 2 (IMPDH2) from Mycobacterium tuberculosis (Mtb) is an attractive drug target....

  • Multi Drug and Other Forms of Drug Resistant Tuberculosis Are Uncommon among Treatment Naïve Tuberculosis Patients in Tanzania. Nagu, Tumaini J.; Aboud, Said; Mwiru, Ramadhani; Matee, Mecky; Fawzi, Wafaie; Mugusi, Ferdinand // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Background: Surveillance and effective management of drug resistance is important to sustaining tuberculosis (TB) control efforts. We aimed to determine resistance rates to first line anti tuberculosis drugs and to describe factors associated with the resistance to any of the first line anti...

  • MEDICINAL CHEMISTRY AND DEVELOPMENT OF ANTITUBERCULAR DRUGS. Kumar, Piyush; Rawat, Pinki; Singh, Pooja // International Journal of Pharmaceutical Sciences & Research;Jun2013, Vol. 4 Issue 6, p2080 

    Tuberculosis (TB) is an ancient disease that has caused inestimable suffering and claimed millions of lives over the centuries. Resistant strains of Mycobacterium tuberculosis have slowly emerged especially in developing countries due to the lack of health care organisation in order to provide...

  • Extensively drug-resistant tuberculosis: epidemiology and management. Matteelli, Alberto; Roggi, Alberto; Carvalho, Anna C. C. // Clinical Epidemiology;2014, Vol. 6, p111 

    The advent of antibiotics for the treatment of tuberculosis (TB) represented a major breakthrough in the fight against the disease. However, since its first use, antibiotic therapy has been associated with the emergence of resistance to drugs. The incorrect use of anti-TB drugs, either due to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics